Field trial of the efficacy of a previously proposed regimen using minocycline and rifampin sequentially for the elimination of meningococci from healthy carriers

L. F. Devine, Richard B Pollard, P. E. Krumpe, E. S. Hoy, R. E. Mammen, C. H. Miller, R. O. Peckinpaugh

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

A field trial of a previously proposed regimen of treatment for the elimination of meningococci from the nasopharynges of healthy carriers was conducted in a naval recruit camp. The regimen of treatment for each man consisted of six consecutive doses given at 12 hr intervals in the following sequence: 200, 100 and 100 mg of minocycline given at 0, 12 and 24 hours followed by 600 mg of rifampin given at 36, 48 and 60 hr, respectively. Nasopharyngeal cultures were taken at 24 hours prior to treatment and at 60 to 84 hours after termination of treatment. Twelve per cent of the men were cultured weekly and all men within 3 days of graduation. There were 3863 men cultured 24 hr prior to treatment who received all doses of the drug and were recultured 60 to 84 hr after treatment. There were 1258 meningococcal carriers prior to treatment and seven carriers after treatment. One of the seven strains isolated 60 to 84 hr after treatment was a rifampin resistant group Y strain. All seven meningococcal strains were sensitive to minocycline. The rifampin resistant group Y strains subsequently spread to some of the other treated and untreated men. Six weeks after the last treated men were graduated, no more rifampin resistant strains were isolated. Minocycline resistant strains were not isolated at any time before or after treatment. Thirty five rifampin resistant strains were isolated from treated and 20 from untreated men within 3 days of graduation.

Original languageEnglish (US)
Pages (from-to)394-401
Number of pages8
JournalAmerican Journal of Epidemiology
Volume97
Issue number6
StatePublished - 1973
Externally publishedYes

Fingerprint

Minocycline
Neisseria meningitidis
Rifampin
Therapeutics
Nasopharynx

ASJC Scopus subject areas

  • Epidemiology

Cite this

Field trial of the efficacy of a previously proposed regimen using minocycline and rifampin sequentially for the elimination of meningococci from healthy carriers. / Devine, L. F.; Pollard, Richard B; Krumpe, P. E.; Hoy, E. S.; Mammen, R. E.; Miller, C. H.; Peckinpaugh, R. O.

In: American Journal of Epidemiology, Vol. 97, No. 6, 1973, p. 394-401.

Research output: Contribution to journalArticle

@article{05bbaf06bf7e4d9e994725dbe64dfe96,
title = "Field trial of the efficacy of a previously proposed regimen using minocycline and rifampin sequentially for the elimination of meningococci from healthy carriers",
abstract = "A field trial of a previously proposed regimen of treatment for the elimination of meningococci from the nasopharynges of healthy carriers was conducted in a naval recruit camp. The regimen of treatment for each man consisted of six consecutive doses given at 12 hr intervals in the following sequence: 200, 100 and 100 mg of minocycline given at 0, 12 and 24 hours followed by 600 mg of rifampin given at 36, 48 and 60 hr, respectively. Nasopharyngeal cultures were taken at 24 hours prior to treatment and at 60 to 84 hours after termination of treatment. Twelve per cent of the men were cultured weekly and all men within 3 days of graduation. There were 3863 men cultured 24 hr prior to treatment who received all doses of the drug and were recultured 60 to 84 hr after treatment. There were 1258 meningococcal carriers prior to treatment and seven carriers after treatment. One of the seven strains isolated 60 to 84 hr after treatment was a rifampin resistant group Y strain. All seven meningococcal strains were sensitive to minocycline. The rifampin resistant group Y strains subsequently spread to some of the other treated and untreated men. Six weeks after the last treated men were graduated, no more rifampin resistant strains were isolated. Minocycline resistant strains were not isolated at any time before or after treatment. Thirty five rifampin resistant strains were isolated from treated and 20 from untreated men within 3 days of graduation.",
author = "Devine, {L. F.} and Pollard, {Richard B} and Krumpe, {P. E.} and Hoy, {E. S.} and Mammen, {R. E.} and Miller, {C. H.} and Peckinpaugh, {R. O.}",
year = "1973",
language = "English (US)",
volume = "97",
pages = "394--401",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Field trial of the efficacy of a previously proposed regimen using minocycline and rifampin sequentially for the elimination of meningococci from healthy carriers

AU - Devine, L. F.

AU - Pollard, Richard B

AU - Krumpe, P. E.

AU - Hoy, E. S.

AU - Mammen, R. E.

AU - Miller, C. H.

AU - Peckinpaugh, R. O.

PY - 1973

Y1 - 1973

N2 - A field trial of a previously proposed regimen of treatment for the elimination of meningococci from the nasopharynges of healthy carriers was conducted in a naval recruit camp. The regimen of treatment for each man consisted of six consecutive doses given at 12 hr intervals in the following sequence: 200, 100 and 100 mg of minocycline given at 0, 12 and 24 hours followed by 600 mg of rifampin given at 36, 48 and 60 hr, respectively. Nasopharyngeal cultures were taken at 24 hours prior to treatment and at 60 to 84 hours after termination of treatment. Twelve per cent of the men were cultured weekly and all men within 3 days of graduation. There were 3863 men cultured 24 hr prior to treatment who received all doses of the drug and were recultured 60 to 84 hr after treatment. There were 1258 meningococcal carriers prior to treatment and seven carriers after treatment. One of the seven strains isolated 60 to 84 hr after treatment was a rifampin resistant group Y strain. All seven meningococcal strains were sensitive to minocycline. The rifampin resistant group Y strains subsequently spread to some of the other treated and untreated men. Six weeks after the last treated men were graduated, no more rifampin resistant strains were isolated. Minocycline resistant strains were not isolated at any time before or after treatment. Thirty five rifampin resistant strains were isolated from treated and 20 from untreated men within 3 days of graduation.

AB - A field trial of a previously proposed regimen of treatment for the elimination of meningococci from the nasopharynges of healthy carriers was conducted in a naval recruit camp. The regimen of treatment for each man consisted of six consecutive doses given at 12 hr intervals in the following sequence: 200, 100 and 100 mg of minocycline given at 0, 12 and 24 hours followed by 600 mg of rifampin given at 36, 48 and 60 hr, respectively. Nasopharyngeal cultures were taken at 24 hours prior to treatment and at 60 to 84 hours after termination of treatment. Twelve per cent of the men were cultured weekly and all men within 3 days of graduation. There were 3863 men cultured 24 hr prior to treatment who received all doses of the drug and were recultured 60 to 84 hr after treatment. There were 1258 meningococcal carriers prior to treatment and seven carriers after treatment. One of the seven strains isolated 60 to 84 hr after treatment was a rifampin resistant group Y strain. All seven meningococcal strains were sensitive to minocycline. The rifampin resistant group Y strains subsequently spread to some of the other treated and untreated men. Six weeks after the last treated men were graduated, no more rifampin resistant strains were isolated. Minocycline resistant strains were not isolated at any time before or after treatment. Thirty five rifampin resistant strains were isolated from treated and 20 from untreated men within 3 days of graduation.

UR - http://www.scopus.com/inward/record.url?scp=0015875462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015875462&partnerID=8YFLogxK

M3 - Article

C2 - 4197420

AN - SCOPUS:0015875462

VL - 97

SP - 394

EP - 401

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 6

ER -